Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostatin plus concurrent chemoradiotherapy for head and neck cancer
ChiCTR-TRC-08000280Phase 2Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of endostar in head and neck cancer (HNC) (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoints: Clinical benefit rate, Response rate and 4 more. Started Jan 2009; status: completed.
02
Drugs
endostar
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on ChiCTR-TRC-08000280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000280.